by Jenn Porter | Jun 4, 2020 | Canadian Regulatory, Natural Health Products, OTC Drugs
Health Canada has recently released updates applicable to Natural Health Products and Non-Prescription Drug Regulations. Beginning July 1st, associated industries will be able to distribute certain types of these products as free samples. Distribution of NHP and...
by Jenn Porter | May 12, 2020 | Canadian Regulatory, OTC Drugs, Research/Science/Technology, U.S. Regulatory, Uncategorized
Recently, Health Canada announced that the Regulatory Enrolment Process (REP) will be mandatory to use as of October 1, 2020. The Health Products and Food Branch (HPFB) will be implementing this single window for transmission of regulatory transactions in electronic...
by Jenn Porter | Apr 28, 2020 | Canadian Regulatory, Cosmetics, Innovation, Natural Health Products, OTC Drugs, Research/Science/Technology, U.S. Regulatory
A couple of years ago the world began legalizing recreational cannabis, bringing it into the cosmetic industry. Since then, it has been reported that the cosmetic CBD market has a net worth of 710 million US dollars and is projected to have a net worth of 959 million...
by Jenn Porter | Mar 27, 2020 | Canadian Regulatory, Cosmetics, European Regulatory, Medical Devices, Natural Health Products, OTC Drugs, Research/Science/Technology, U.S. Regulatory
Health Canada and the Public Health Agency of Canada continue to put their best efforts forward with assisting the supply and demand of products for Canadians amidst the battle against the COVID-19 pandemic. Health Canada has expanded their previously released DEL...
by Jenn Porter | Mar 12, 2020 | Canadian Regulatory, Cosmetics, European Regulatory, Medical Devices, OTC Drugs, Research/Science/Technology, U.S. Regulatory
The International Fragrance Association (IFRA) have recently released the 49th amendment to their Code of Practice, the largest update in years. IFRA has been promoting the safety of fragrances in products since 1973. The self-regulating body has been promoting safety...
by Jenn Porter | Feb 20, 2020 | Canadian Regulatory, Cosmetics, European Regulatory, Events/Company Updates, Innovation, Medical Devices, Natural Health Products, OTC Drugs, Our View, Research/Science/Technology, U.S. Regulatory, Uncategorized
An entrepreneur recently told me she had discovered a new use for an old molecule. She was not sure about moving ahead with it because patent protection was not solid. I said “so what”, just to be provocative. Then I told her that having patent protection was not the...
Recent Comments